Screener
aTyr Pharma ATYR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's net income?
- aTyr Pharma (ATYR) reported net income of -$10.31M in Q2 2026.
- How has aTyr Pharma's net income changed year-over-year?
- aTyr Pharma's net income increased by 47.2% year-over-year, from -$19.53M to -$10.31M.
- What is the long-term trend for aTyr Pharma's net income?
- Over 4 years (2021 to 2025), aTyr Pharma's net income has grown at a 21.7% compound annual growth rate (CAGR), from -$33.77M to -$74.12M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about aTyr Pharma's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude